Imec and MiDiagnostics to Commercialize COVID-19 Breath Sampler
| Date | 25th, Oct 2021 |
|---|---|
| Source | Photonics Media - Scientific News Websites |
DESCRIPTION
Imec, a research and innovation hub in nanoelectronics and digital technology, has signed a nonexclusive licensing agreement with miDiagnostics, a spinoff of imec in collaboration with Johns Hopkins University, to commercialize technology that captures aerosols and droplets from exhaled breath. The patented technology from imec screens for viral RNA through miDiagnostics’ ultrafast PCR capabilities.